These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28912210)

  • 1. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Guimarães PO; Granger CB; Stebbins A; Chiswell K; Held C; Hochman JS; Krug-Gourley S; Lonn E; Lopes RD; Stewart RAH; Vinereanu D; Wallentin L; White HD; Hagström E; Danchin N
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28912210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Darapladib for preventing ischemic events in stable coronary heart disease.
    ; White HD; Held C; Stewart R; Tarka E; Brown R; Davies RY; Budaj A; Harrington RA; Steg PG; Ardissino D; Armstrong PW; Avezum A; Aylward PE; Bryce A; Chen H; Chen MF; Corbalan R; Dalby AJ; Danchin N; De Winter RJ; Denchev S; Diaz R; Elisaf M; Flather MD; Goudev AR; Granger CB; Grinfeld L; Hochman JS; Husted S; Kim HS; Koenig W; Linhart A; Lonn E; López-Sendón J; Manolis AJ; Mohler ER; Nicolau JC; Pais P; Parkhomenko A; Pedersen TR; Pella D; Ramos-Corrales MA; Ruda M; Sereg M; Siddique S; Sinnaeve P; Smith P; Sritara P; Swart HP; Sy RG; Teramoto T; Tse HF; Watson D; Weaver WD; Weiss R; Viigimaa M; Vinereanu D; Zhu J; Cannon CP; Wallentin L
    N Engl J Med; 2014 May; 370(18):1702-11. PubMed ID: 24678955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
    White H; Held C; Stewart R; Watson D; Harrington R; Budaj A; Steg PG; Cannon CP; Krug-Gourley S; Wittes J; Trivedi T; Tarka E; Wallentin L
    Am Heart J; 2010 Oct; 160(4):655-61. PubMed ID: 20934559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Age- and Sex-Specific Nomograms of Global Plaque Burden on Coronary Computed Tomography Angiography for Major Cardiac Events.
    Naoum C; Berman DS; Ahmadi A; Blanke P; Gransar H; Narula J; Shaw LJ; Kritharides L; Achenbach S; Al-Mallah MH; Andreini D; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow B; Cury RC; DeLago A; Dunning A; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann PA; Kim YJ; Maffei E; Marquez H; Pontone G; Raff G; Rubinshtein R; Villines TC; Min J; Leipsic J
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
    Lansky AJ; Ng VG; Maehara A; Weisz G; Lerman A; Mintz GS; De Bruyne B; Farhat N; Niess G; Jankovic I; Lazar D; Xu K; Fahy M; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S62-72. PubMed ID: 22421232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease.
    Stewart RAH; Hagström E; Held C; Wang TKM; Armstrong PW; Aylward PE; Cannon CP; Koenig W; López-Sendón JL; Mohler ER; Hadziosmanovic N; Krug-Gourley S; Ramos Corrales MA; Siddique S; Steg PG; White HD; Wallentin L;
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
    O'Donoghue ML; Braunwald E; White HD; Lukas MA; Tarka E; Steg PG; Hochman JS; Bode C; Maggioni AP; Im K; Shannon JB; Davies RY; Murphy SA; Crugnale SE; Wiviott SD; Bonaca MP; Watson DF; Weaver WD; Serruys PW; Cannon CP; ; Steen DL
    JAMA; 2014 Sep; 312(10):1006-15. PubMed ID: 25173516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex is associated with the presence of atherosclerotic plaque hemorrhage and modifies the relation between plaque hemorrhage and cardiovascular outcome.
    Vrijenhoek JE; Den Ruijter HM; De Borst GJ; de Kleijn DP; De Vries JP; Bots ML; Van de Weg SM; Vink A; Moll FL; Pasterkamp G
    Stroke; 2013 Dec; 44(12):3318-23. PubMed ID: 24130138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of lipoprotein-associated phospholipase A
    Prasad M; Lennon R; Barsness GW; Prasad A; Gulati R; Lerman LO; Lerman A
    Int J Cardiol; 2018 Feb; 253():7-13. PubMed ID: 29306475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry.
    Schulman-Marcus J; Hartaigh BÓ; Gransar H; Lin F; Valenti V; Cho I; Berman D; Callister T; DeLago A; Hadamitzky M; Hausleiter J; Al-Mallah M; Budoff M; Kaufmann P; Achenbach S; Raff G; Chinnaiyan K; Cademartiri F; Maffei E; Villines T; Kim YJ; Leipsic J; Feuchtner G; Rubinshtein R; Pontone G; Andreini D; Marques H; Shaw L; Min JK
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):364-372. PubMed ID: 27056154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.
    Stewart RAH; Held C; Krug-Gourley S; Waterworth D; Stebbins A; Chiswell K; Hagstrom E; Armstrong PW; Wallentin L; White H
    J Am Heart Assoc; 2019 Apr; 8(7):e010641. PubMed ID: 30897999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
    Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
    J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Kato ET; Cannon CP; Blazing MA; Bohula E; Guneri S; White JA; Murphy SA; Park JG; Braunwald E; Giugliano RP
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tooth loss is independently associated with poor outcomes in stable coronary heart disease.
    Vedin O; Hagström E; Budaj A; Denchev S; Harrington RA; Koenig W; Soffer J; Sritara P; Stebbins A; Stewart RH; Swart HP; Viigimaa M; Vinereanu D; Wallentin L; White HD; Held C;
    Eur J Prev Cardiol; 2016 May; 23(8):839-46. PubMed ID: 26672609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in coronary artery disease: pathological observations.
    Yahagi K; Davis HR; Arbustini E; Virmani R
    Atherosclerosis; 2015 Mar; 239(1):260-7. PubMed ID: 25634157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.
    Vedin O; Hagström E; Stewart R; Brown R; Krug-Gourley S; Davies R; Wallentin L; White H; Held C
    Eur J Prev Cardiol; 2013 Aug; 20(4):678-85. PubMed ID: 22496275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease.
    Kataoka Y; Puri R; Hammadah M; Duggal B; Uno K; Kapadia SR; Tuzcu EM; Nissen SE; King P; Nicholls SJ
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.